Lutetium-177 therapy in Valued Med Hub Hospitals

Lutetium-177 therapy at Valued Med Hub Hospitals in Istanbul, Turkey, provides a targeted form of radionuclide treatment for patients with advanced cancer. This procedure uses a radioactive liquid to find and destroy cancer cells while helping to protect surrounding healthy tissue. The hospital holds an International Health Tourism Authorization Certificate from the Turkish government, confirming its status as a recognized center for international medical care.

How Lutetium-177 Therapy Works

Lutetium-177 therapy is a type of internal radiation treatment. A radioactive source is placed inside the body to target specific tumors directly. The goal of this therapy is to kill cancer cells and shrink tumors to manageable sizes. Doctors use it to treat the disease, lower the chance of it coming back, or help relieve pain and other symptoms.

Advanced Imaging and Monitoring

The Radiation Oncology Department uses PET-CT imaging as a key part of the treatment process. This imaging helps doctors see exactly how far the cancer has spread before starting therapy. After the Lutetium-177 cycles, PET-CT scans show how well the disease is responding to the radiation. This data helps the medical team adjust the treatment plan for each patient.

Care for International Patients

Valued Med Hub Hospitals serves patients from Europe, the USA, Australia, and Arab League states. The facility is accredited by the Turkish Medical Association and focuses on making the stay comfortable for travelers. Support services include airport transfers and coordination for hotel stays. Patients also receive help from interpreters and have access to follow-up care after they return home.

To learn more about receiving radionuclide therapy in Istanbul, you can leave a request on Bookimed.